Trial Profile
Phase II Clinical Study of DD-687 - Single arm, unblinded, uncontrolled Clinical Study in Healthy Japanese Infants
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs DTP poliovirus vaccine (Primary)
- Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Daiichi Sankyo Company
- 25 May 2016 New trial record